Three-dimensional (3D) printing is well acknowledged to constitute an important technology
in tissue engineering, largely due to the increasing global demand for organ replacement …

Medicine today faces the combined challenge of an increasing number of untreatable
diseases and fewer drugs reaching the clinic. While pharmaceutical companies have …

In vitro liver models allow the investigation of the cell behavior in disease conditions or in
response to changes in the microenvironment. A major challenge in liver tissue engineering …

One of the major mechanisms of drug-induced liver injury includes mitochondrial
perturbation and dysfunction. This is not a surprise, given that mitochondria are essential …

It is estimated that 25% of the world's population has non-alcoholic fatty liver disease. This
disease can advance to a more severe form, non-alcoholic steatohepatitis (NASH), a …

Abstract 3D bioprinting, a vital tool in tissue engineering, drug testing, and disease
modeling, is increasingly integrated with machine learning (ML) and artificial intelligence …

Liver diseases are the primary reason for morbidity and mortality in the world. Owing to a
shortage of organ donors and postoperative immune rejection, patients routinely suffer from …

Rapid development of tissue engineering in recent years has increased the importance of
three-dimensional (3D) bioprinting technology as novel strategy for fabrication functional 3D …

Additive manufacturing, or 3D printing, has made incredible steps over the last 30 years and
is now being widely used for healthcare applications. There has been increasing research …

The engineering construction of the liver has attracted enormous attention. Organoids, as
emerging miniature three-dimensional cultivation units, hold significant potential in the …